keyword
MENU ▼
Read by QxMD icon Read
search

Helicobacter eradication

keyword
https://www.readbyqxmd.com/read/28440977/low-re-infection-rate-of-helicobacter-pylori-after-successful-eradication-in-thailand-a-2-years-study
#1
Ratha Korn Vilaichone, Arti Wongcha Um, Peranart Chotivitayatarakorn
Background: H. pylori is an important cause of chronic gastritis, peptic ulcers and gastric cancer. Re-infection rates after successful eradication vary in different regions of the world but only limited studies have been performed in ASEAN Countries to clarify this important issue. The present study was designed to evaluate the H. pylori re-infection rate and predictors of re-infection in Thailand. Methods: We recruited patients with chronic gastritis after 1 and 2 years successful H. pylori eradication from Thammasat University Hospital, Pathumthani (Central urban area) and Maesod district, Tak (Northern rural area), Thailand...
March 1, 2017: Asian Pacific Journal of Cancer Prevention: APJCP
https://www.readbyqxmd.com/read/28440099/antibiotic-susceptibility-of-helicobacter-pylori-in-iceland
#2
Anna Ingibjorg Gunnarsdottir, Hallgrimur Gudjonsson, Hjordis Hardardottir, Karen Drofn Jonsdottir, Einar Stefan Bjornsson
BACKGROUND: Increasing resistance of Helicobacter pylori (H. pylori) to antibiotics calls for constant re-evaluation of multidrug regimens that have been used to eradicate the infection. The aim of this study was to evaluate the current antibiotic susceptibility of H. pylori in an Icelandic cohort. METHODS: Patients referred for gastroscopy were recruited prospectively. Those found to have a positive rapid urease test were included in the study. Susceptibility testing was conducted by the Epsilometer test (E-test) method for ampicillin, clarithromycin, levofloxacin, metronidazole and tetracycline...
April 25, 2017: Infectious Diseases
https://www.readbyqxmd.com/read/28437803/prevalence-of-helicobacter-pylori-infection-among-blood-donors-in-saxony-anhalt-germany-a-region-at-intermediate-risk-for-gastric-cancer
#3
Caspar Franck, Armin Hoffmann, Alexander Link, Christian Schulz, Kerstin Wuttig, Elke Becker, Marcell Heim, Marino Venerito, Peter Malfertheiner
Background In the federal state of Saxony-Anhalt, gastric cancer (GC) incidence ranks among the highest in Germany. Helicobacter pylori prevalence is a surrogate marker for GC risk in a given population. In 2010 we reported an H. pylori seroprevalence of 44.4 % in patients at the emergency ward of the University Hospital of Magdeburg, the capital of Saxony-Anhalt. Our aim is to update these findings in a cohort of healthy blood donors from the same region. Materials and methods The sera of 516 consecutive blood donors (40...
April 24, 2017: Zeitschrift Für Gastroenterologie
https://www.readbyqxmd.com/read/28427781/smoking-increases-the-likelihood-of-helicobacter-pylori-treatment-failure
#4
David Itskoviz, Doron Boltin, Haim Leibovitzh, Tsachi Tsadok Perets, Doron Comaneshter, Arnon Cohen, Yaron Niv, Zohar Levi
BACKGROUND AND AIMS: Data regarding the impact of smoking on the success of Helicobacter pylori (H. pylori) eradication are conflicting, partially due to the fact that sociodemographic status is associated with both smoking and H. pylori treatment success. We aimed to assess the effect of smoking on H. pylori eradication rates after controlling for sociodemographic confounders. METHODS: Included were subjects aged 15 years or older, with a first time positive C(13)-urea breath test (C(13)-UBT) between 2007 to 2014, who underwent a second C(13)-UBT after receiving clarithromycin-based triple therapy...
March 27, 2017: Digestive and Liver Disease
https://www.readbyqxmd.com/read/28425141/efficacy-of-helicobacter-pylori-eradication-therapies-in-korea-a-systematic-review-and-network-meta-analysis
#5
REVIEW
Yoon Suk Jung, Chan Hyuk Park, Jung Ho Park, Eunwoo Nam, Hang Lak Lee
BACKGROUND: The efficacy of Helicobacter pylori eradication regimens may depend on the country where the studies were performed because of the difference in antibiotic resistance. We aimed to analyze the efficacy of H. pylori eradication regimens in Korea where clarithromycin resistance rate is high. METHODS: We searched for all relevant randomized controlled trials published until November 2016 that investigated the efficacy of H. pylori eradication therapies in Korea...
April 19, 2017: Helicobacter
https://www.readbyqxmd.com/read/28424674/global-fecal-and-plasma-metabolic-dynamics-related-to-helicobacter-pylori-eradication
#6
Theresa Wan-Chen Yap, Alex Hwong-Ruey Leow, Ahmad Najib Azmi, Damien L Callahan, Guillermo I Perez-Perez, Mun-Fai Loke, Khean-Lee Goh, Jamuna Vadivelu
Background:Helicobacter pylori colonizes the gastric mucosa of more than half of the world's population. There is increasing evidence H. pylori protects against the development of obesity and childhood asthma/allergies in which the development of these diseases coincide with transient dysbiosis. However, the mechanism underlying the association of H. pylori eradication with human metabolic and immunological disorders is not well-established. In this study, we aimed to investigate the local and systemic effects of H...
2017: Frontiers in Microbiology
https://www.readbyqxmd.com/read/28422059/mismatch-between-probiotic-benefits-in-trials-versus-food-products
#7
Mary J Scourboutakos, Beatriz Franco-Arellano, Sarah A Murphy, Sheida Norsen, Elena M Comelli, Mary R L'Abbé
Probiotic food products contain a variety of different bacterial strains and may offer different health effects. The objective was to document the prevalence and dosage of probiotic strains in the Canadian food supply and to review the literature investigating these strains in order to understand what health benefits these products may offer. The Food Label Information Program was used to identify probiotic-containing products in the food supply. PubMed, Web of Science, and Embase were searched for randomized controlled trials that tested the health effects of these strains in humans...
April 19, 2017: Nutrients
https://www.readbyqxmd.com/read/28413207/rate-of-active-helicobacter-pylori-infection-among-symptomatic-patients-of-pakistan
#8
F Rasheed, A Yameen, T Ahmad, R Bilal
Only few epidemiological studies have examined the rate of active H. pylori infection in the symptomatic population in Pakistan. This retrospective study presents the laboratory data collected during the past 13 years (2002 to 2015) from 2315 symptomatic patients referred to the BreathMAT Lab, Nuclear Medicine, Oncology and Radiotherapy Institute, Islamabad for the diagnosis of active H. pylori infection using the (13)C Urea Breath Test. Rate of infection and its association with gender and age were evaluated...
April 2017: Malaysian Journal of Pathology
https://www.readbyqxmd.com/read/28413079/mexican-consensus-on-dyspepsia
#9
R Carmona-Sánchez, O Gómez-Escudero, M Zavala-Solares, M V Bielsa-Fernández, E Coss-Adame, A I Hernández-Guerrero, F Huerta-Iga, M E Icaza-Chávez, M A Lira-Pedrín, J A Lizárraga-López, A López-Colombo, A Noble-Lugo, J Pérez-Manauta, R H Raña-Garibay, J M Remes-Troche, J L Tamayo, L F Uscanga, F Zamarripa-Dorsey, M A Valdovinos Díaz, J A Velarde-Ruiz Velasco
Since the publication of the 2007 dyspepsia guidelines of the Asociación Mexicana de Gastroenterología, there have been significant advances in the knowledge of this disease. A systematic search of the literature in PubMed (01/2007 to 06/2016) was carried out to review and update the 2007 guidelines and to provide new evidence-based recommendations. All high-quality articles in Spanish and English were included. Statements were formulated and voted upon using the Delphi method. The level of evidence and strength of recommendation of each statement were established according to the GRADE system...
April 13, 2017: Revista de Gastroenterología de México
https://www.readbyqxmd.com/read/28410586/efficacy-and-safety-of-jianzhong-decoction-in-treating-peptic-ulcers-a-meta-analysis-of-58-randomised-controlled-trials-with-5192-patients
#10
Yan Sun, Jinping Zhang, Yuanyuan Chen
BACKGROUND: Jianzhong decoction is widely used to treat peptic ulcers; however, due to lack of systematic evaluations, its clinical efficacy remains controversial. We performed meta-analysis to evaluate the efficacy and safety of Jianzhong decoction in treating peptic ulcers. METHODS: Studies were systematically retrieved from PubMed, Embase, Cochrane library, China National Knowledge Infrastructure, Wanfang Database, Chongqing VIP, China Biology Medicine disc (CBMdisc), and references cited in related studies/reviews...
April 14, 2017: BMC Complementary and Alternative Medicine
https://www.readbyqxmd.com/read/28408993/real-world-helicobacter-pylori-diagnosis-in-patients-referred-for-esophagoduodenoscopy-the-gap-between-guidelines-and-clinical-practice
#11
Dor Shirin, Shay Matalon, Benjamin Avidan, Efrat Broide, Haim Shirin
BACKGROUND AND AIMS: Histopathology is the most accurate test to detect H. pylori when performed correctly with unknown validity in daily practice clinic settings. We aimed to determine the rate of potentially false-negative H. pylori results that might be due to continued use of proton pump inhibitors (PPIs) in routine endoscopy practice. We also aimed to establish whether gastroenterologists recommend routine cessation of PPIs before esophagogastroduodenoscopy (EGD) and whether they regularly document that biopsies for H...
December 2016: United European Gastroenterology Journal
https://www.readbyqxmd.com/read/28407007/polaprezinc-combined-with-clarithromycin-based-triple-therapy-for-helicobacter-pylori-associated-gastritis-a-prospective-multicenter-randomized-clinical-trial
#12
RANDOMIZED CONTROLLED TRIAL
Bei Tan, Han-Qing Luo, Hong Xu, Nong-Hua Lv, Rui-Hua Shi, He-Sheng Luo, Jian-Sheng Li, Jian-Lin Ren, Yi-You Zou, Yan-Qing Li, Feng Ji, Jing-Yuan Fang, Jia-Ming Qian
The efficacy and safety of polaprezinc combined with triple therapy was compared with triple therapy alone in the eradication of Helicobacter pylori. A randomized, parallel-group, open-label, controlled, prospective multicenter study was conducted in 11 cities in China. Treatment-naive patients with H. pylori-associated gastritis were randomly assigned to one of three arms for a 14-day treatment: Arm A triple therapy (omeprazole 20 mg, amoxicillin 1 g, and clarithromycin 500 mg, each twice daily) plus polaprezinc 75 mg twice daily; Arm B triple therapy plus polaprezinc 150 mg twice daily, or Arm C triple therapy alone...
2017: PloS One
https://www.readbyqxmd.com/read/28406776/gastric-intestinal-metaplasia-an-intermediate-precancerous-lesion-in-the-cascade-of-gastric-carcinogenesis
#13
Tayyab Hamid Malik, Mujtaba Yousef Al Sayahan, Hussain Ali Al Ahmed, Xu Hong
Gastric intestinal metaplasia, an intermediate lesion in the development of intestinal-type gastric cancer, is observed in the milieu of long standing non-atrophic gastritis and atrophic gastritis. Most patients with intestinal metaplasia remain asymptomatic unless cobalamin deficiency occurs secondary to loss of glands (that produce intrinsic factor and acid). Genetic events that predispose to development of gastric intestinal metaplasia remains an enigma. Mechanisms leading to the progression of atrophy to metaplasia still needs to be comprehensively explored...
March 2017: Journal of the College of Physicians and Surgeons—Pakistan: JCPSP
https://www.readbyqxmd.com/read/28406585/association-of-helicobacter-pylori-with-parkinson-s-disease
#14
Kandadai Rukmini Mridula, Rupam Borgohain, Vupparalli Chandrasekhar Reddy, Venkata Chandrasekhar Srinivasarao Bandaru, Turaga Suryaprabha
BACKGROUND AND PURPOSE: Parkinson's disease (PD) is a major neurological disorder that requires lifelong treatment, and the combined presence of Helicobacter pylori (H. pylori) infection can increase the required anti-PD medications. We aim to investigate the effect of H. pylori infection in Indian PD patients. METHODS: We prospectively recruited 36 PD patients from December 2007 to January 2011. All patients underwent a detailed neurological evaluation and serological examination for H...
April 2017: Journal of Clinical Neurology
https://www.readbyqxmd.com/read/28404012/a-non-endoscopic-device-to-sample-the-oesophageal-microbiota-a-case-control-study
#15
Daffolyn R Fels Elliott, Alan W Walker, Maria O'Donovan, Julian Parkhill, Rebecca C Fitzgerald
BACKGROUND: The strongest risk factor for oesophageal adenocarcinoma is reflux disease, and the rising incidence of this coincides with the eradication of Helicobacter pylori, both of which might alter the oesophageal microbiota. We aimed to profile the microbiota at different stages of Barrett's carcinogenesis and investigate the Cytosponge as a minimally invasive tool for sampling the oesophageal microbiota. METHODS: In this case-control study, 16S rRNA gene amplicon sequencing was done on 210 oesophageal samples from 86 patients representing the Barrett's oesophagus progression sequence (normal squamous controls [n=20], non-dysplastic [n=24] and dysplastic Barrett's oesophagus [n=23], and oesophageal adenocarcinoma [n=19]), relevant negative controls, and replicates on the Illumina MiSeq platform...
January 2017: Lancet. Gastroenterology & Hepatology
https://www.readbyqxmd.com/read/28400819/the-role-of-endoscopic-ultrasound-in-the-diagnosis-and-management-of-primary-gastric-lymphoma
#16
REVIEW
Dimitrios Schizas, Ioannis Ntanasis-Stathopoulos, Diamantis I Tsilimigras, Athanasios D Sioulas, Demetrios Moris, Eleftherios Spartalis, Ilias Scotiniotis, Ioannis S Papanikolaou
Endoscopic ultrasound (EUS) is considered a valuable diagnostic tool during the workup of malignant gastric lesions, including primary gastric lymphomas (PGL). Although endoscopy combined with multiple biopsies remains essential in the establishment of PGL diagnosis, EUS utilization in locoregional disease staging has been well documented in the literature. Data also support the possible role of EUS in prediction of response to first-line treatment, that is, Helicobacter pylori eradication. However, its application in the posttreatment setting remains problematic, since concordance rates between endosonography and histology findings during follow-up seem to vary substantially...
2017: Gastroenterology Research and Practice
https://www.readbyqxmd.com/read/28395508/characteristics-of-primary-and-metachronous-gastric-cancers-discovered-after-helicobacter-pylori-eradication-a-multicenter-propensity-score-matched-study
#17
Yuji Maehata, Shotaro Nakamura, Motohiro Esaki, Fumie Ikeda, Tomohiko Moriyama, Risa Hida, Ema Washio, Junji Umeno, Minako Hirahashi, Takanari Kitazono, Takayuki Matsumoto
Background/Aims: Gastric cancers develop even after successful Helicobacter pylori eradication. We aimed to clarify the characteristics of early gastric cancers discovered after H. pylori eradication. Methods: A total of 1,053 patients with early gastric cancer treated by endoscopic submucosal dissection were included. After matching the propensity score, we retrospectively investigated the clinicopathological features of 192 patients, including 96 patients who had undergone successful H...
April 11, 2017: Gut and Liver
https://www.readbyqxmd.com/read/28393827/-possibilities-for-optimization-of-eradication-therapy-for-helicobacter-pylori-infection-in-modern-clinical-practice
#18
D N Andreev, D T Dicheva, I V Maev
A steady decline in the effectiveness of standard eradication therapy (ET) regimens for Helicobacter pylori infection necessitates a search for ways of their optimization, by enhancing the efficiency of treatment protocols and by improving their safety and tolerability. The review systematizes the data available in the literature on main accessible methods for optimizing ET regimens. Among the optimization methods that can considerably enhance the efficiency of ET regimens, one may identify their addition of a bismuth agent (by 10-20%), the use of rebamipide (by 11...
2017: Terapevticheskiĭ Arkhiv
https://www.readbyqxmd.com/read/28391418/randomized-clinical-trial-esomeprazole-bismuth-levofloxacin-and-amoxicillin-or-cefuroxime-as-first-line-eradication-regimens-for-helicobacter-pylori-infection
#19
Wei Fu, Zhiqiang Song, Liya Zhou, Yan Xue, Yu Ding, Baojun Suo, Xueli Tian, Li Wang
BACKGROUND: The eradication of Helicobacter pylori infection remains a challenge, especially in the patients unsuitable to take penicillin. Cephalosporin has the potential to replace amoxicillin for H. pylori eradication. AIMS: To compare the effectiveness, safety, and compliance of amoxicillin- and cefuroxime-containing quadruple regimens in treatment-naïve patients. METHODS: In this open-label randomized control study, 400 patients with H...
April 8, 2017: Digestive Diseases and Sciences
https://www.readbyqxmd.com/read/28388387/treating-helicobacter-pylori-effectively-while-minimizing-misuse-of-antibiotics
#20
REVIEW
Akiko Shiotani, Hong Lu, Maria Pina Dore, David Y Graham
Experts now recommend that all Helicobacter pylori infections be eradicated unless there are compelling reasons not to. As with other infectious diseases, effective therapy should be based on susceptibility.
April 2017: Cleveland Clinic Journal of Medicine
keyword
keyword
6937
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"